Value
9.3/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 9.9 |
| P/S | 10.0 |
| EV/EBITDA | 8.9 |
| Fwd P/E | 10.0 |
| PEG | 10.0 |
| Analyst target | 7.5 |
- ▸Forward P/E: 4.0x
- ▸PEG: 0.24
- ▸Attractively valued
HLF · Why this verdict
Why Herbalife (HLF) is rated BUY WAIT
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictBUY WAIT
Overall score6.0/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
Herbalife trades at an extreme discount — forward price-to-earnings below 4x and a PEG of 0.23 — backed by exceptional free cash flow conversion at 146% of net income and a recent return to earnings beats, though concentrated product and customer exposure and substantial options-market skepticism limit the setup to a modest initial position.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Weight management products account for over half of revenue at 54.5%, and the distribution network relies entirely on independent members — a dual concentration that leaves the business highly sensitive to category trends and the health of the direct-sales channel. Bear case | Revenue should remain stable, confirming the concentrated model is resilient; if revenue grows above 5% year-over-year for three consecutive quarters, it would suggest the concentration is a competitive advantage rather than a structural constraint. | →Stable |
| CounterRevenue growing more than 5% year-over-year for 3 consecutive quarters would indicate the concentrated direct-sales network is expanding rather than contracting, undermining the concentration vulnerability claim. | ||
Free cash flow represents 146% of net income, meaning the business is generating substantially more cash than reported earnings indicate — a quality signal that underpins the valuation argument and confirms the business is not masking a cash-depleting structure beneath an attractive-looking income statement. Quality | Free cash flow conversion should remain above 100% of net income for four consecutive quarters, demonstrating that the cash generation is structural rather than driven by one-time working-capital tailwinds. | →Stable |
| CounterConversion ratios substantially above 100% can arise from temporary working-capital movements or timing of capital expenditures rather than durable cash efficiency; if the ratio falls below 80% for two consecutive quarters, the quality foundation supporting the value thesis weakens materially. | ||
At a forward price-to-earnings of 3.8x and a PEG of 0.23, the stock screens at a deep discount relative to earnings power, with price-to-sales at the top of the peer group — implying that the market is pricing in a degree of structural impairment that the current financial results do not support. Value | The forward multiple should expand toward a more normalized range of 6–8x over 12 months as evidence of earnings stability attracts value-oriented institutional capital. | →Stable |
| CounterAn extremely low multiple can reflect rational repricing of genuine structural decline rather than a mispricing opportunity; if the revenue trajectory deteriorates materially, the earnings base supporting the apparent cheapness may shrink faster than the multiple can expand. | ||
The company delivered beats in the most recent quarter and two quarters prior — surprises of 5.44%, 8.42%, and 18.59% — with one intervening miss of 5.59%, indicating that the earnings trajectory has re-established positive momentum and the single off-quarter was not the start of a deteriorating trend. Earnings | Earnings beats should continue in the next two reported quarters, supporting upward estimate revisions and reinforcing the view that the business is on stable financial footing. | →Stable |
| CounterThree out of four beats with one miss is a mixed record; if the recent beat was driven by cost discipline rather than revenue growth, the beat streak may stall once efficiency gains are exhausted. | ||
A put/call ratio of 2.43 and implied volatility near 87% place the options market in a heavily bearish stance, indicating substantial institutional hedging or directional bets against the stock that can create a persistent drag on price appreciation even as fundamentals improve. Risk | Continued earnings beats should cause the put/call ratio to normalize below 1.5 and implied volatility to compress toward 55% within two to three quarters. | →Stable |
| CounterElevated put/call ratios and high implied volatility in small-cap consumer names can persist well beyond 12 months when structural questions about the business model remain open, making normalization timing highly uncertain. | ||
Weight management products account for over half of revenue at 54.5%, and the distribution network relies entirely on independent members — a dual concentration that leaves the business highly sensitive to category trends and the health of the direct-sales channel.
→StableBear case
- Expectation
- Revenue should remain stable, confirming the concentrated model is resilient; if revenue grows above 5% year-over-year for three consecutive quarters, it would suggest the concentration is a competitive advantage rather than a structural constraint.
CounterRevenue growing more than 5% year-over-year for 3 consecutive quarters would indicate the concentrated direct-sales network is expanding rather than contracting, undermining the concentration vulnerability claim.
Free cash flow represents 146% of net income, meaning the business is generating substantially more cash than reported earnings indicate — a quality signal that underpins the valuation argument and confirms the business is not masking a cash-depleting structure beneath an attractive-looking income statement.
→StableQuality
- Expectation
- Free cash flow conversion should remain above 100% of net income for four consecutive quarters, demonstrating that the cash generation is structural rather than driven by one-time working-capital tailwinds.
CounterConversion ratios substantially above 100% can arise from temporary working-capital movements or timing of capital expenditures rather than durable cash efficiency; if the ratio falls below 80% for two consecutive quarters, the quality foundation supporting the value thesis weakens materially.
At a forward price-to-earnings of 3.8x and a PEG of 0.23, the stock screens at a deep discount relative to earnings power, with price-to-sales at the top of the peer group — implying that the market is pricing in a degree of structural impairment that the current financial results do not support.
→StableValue
- Expectation
- The forward multiple should expand toward a more normalized range of 6–8x over 12 months as evidence of earnings stability attracts value-oriented institutional capital.
CounterAn extremely low multiple can reflect rational repricing of genuine structural decline rather than a mispricing opportunity; if the revenue trajectory deteriorates materially, the earnings base supporting the apparent cheapness may shrink faster than the multiple can expand.
The company delivered beats in the most recent quarter and two quarters prior — surprises of 5.44%, 8.42%, and 18.59% — with one intervening miss of 5.59%, indicating that the earnings trajectory has re-established positive momentum and the single off-quarter was not the start of a deteriorating trend.
→StableEarnings
- Expectation
- Earnings beats should continue in the next two reported quarters, supporting upward estimate revisions and reinforcing the view that the business is on stable financial footing.
CounterThree out of four beats with one miss is a mixed record; if the recent beat was driven by cost discipline rather than revenue growth, the beat streak may stall once efficiency gains are exhausted.
A put/call ratio of 2.43 and implied volatility near 87% place the options market in a heavily bearish stance, indicating substantial institutional hedging or directional bets against the stock that can create a persistent drag on price appreciation even as fundamentals improve.
→StableRisk
- Expectation
- Continued earnings beats should cause the put/call ratio to normalize below 1.5 and implied volatility to compress toward 55% within two to three quarters.
CounterElevated put/call ratios and high implied volatility in small-cap consumer names can persist well beyond 12 months when structural questions about the business model remain open, making normalization timing highly uncertain.
Per-dimension breakdown
Quality
6.4/10data confidence 100%| Component | Sub-score |
|---|---|
| ROA | 7.7 |
| Gross margin | 10.0 |
| Op margin | 4.3 |
| Net margin | 2.3 |
| Current ratio | 4.7 |
| FCF quality | 9.9 |
| Moat | 6.4 |
| Rule of 40 | 3.0 |
| Piotroski F | 8.9 |
- ▸Excellent cash conversion: 146% FCF/NI
- ▸Rule of 40: 15 (fail)
- ▸Strong Piotroski F-Score: 8/9
Growth
4.8/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 4.4 |
| EPS growth | 5.3 |
Momentum
5.6/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 2.9 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 5.2 |
| Volume | 0.0 |
- ▸Overbought bear rally (RSI 72)
- ▸Volume accumulation (rising OBV)
- ▸Below 200-MA but MA still rising (+3.1%/30d) — pullback in uptrend, not confirmed weakness
Sentiment
6.7/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 5.0 |
| Price target | 9.4 |
| erm sentiment | 6.1 |
- ▸Analyst upside: 47%
Insider
3.8/10data confidence 75%| Component | Sub-score |
|---|---|
| materiality | 3.0 |
| insider conviction | 3.2 |
| holder change | 5.1 |
- ▸Notable insider selling — $2,538,243 (0.196% of mkt cap)
Peer rank
6.4/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 9.6 |
| quality rank | 4.6 |
| growth rank | 6.5 |
- ▸Attractive P/E vs peers
Technical
1.9/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 1.4 |
| support resistance | 2.1 |
| 52w position | 2.2 |
Risk (lower is worse)
5.1/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 5.9 |
| days to cover | 5.8 |
| volatility | 2.7 |
| put call | 6.4 |
| implied vol | 0.0 |
| max pain risk | 7.0 |
| beta | 7.7 |
- ▸High IV: 84%
- ▸Concentration risks: 2 HIGH, 1 MED (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
6.0/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 6.5 |
| earnings history | 6.7 |
| earnings timing | 5.0 |
| surprise avg | 5.9 |
- ▸Strong earnings: 3B/1M
How the verdict was assembled
Engine trigger
Maintain position. Not compelling to add more. | News modifier +1 (HOLD_IF_HOLDING → STRONG_BUY_WAIT).
Engine technical detail
verdict_path:
L4:PATH_F_HOLD|L3:NEWS_MOD=+1|ENTRY_STICKY:PRIOR_STILL_VIABLEPassed (8)
- MOMENTUM:5.6>=5.5
- ASYMMETRY:2.4>=1.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:41d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (0)
none
Warning (0)
none
Reward-to-Risk
2.41
Upside
+25.0%
Downside
10.3%
Sizing output
STARTER
SetupUNKNOWN — No clear chart pattern; technical signals are mixed
EdgeNO_EDGE — No clear edge identified
SuitabilityAGGRESSIVE — MCap $1.3B<$5B
Investment implication
None of the engine's positive-conviction paths (C-quality, D-momentum) triggered — the F-path HOLD reflects balanced signals. Strongest-cleared gate: MOMENTUM:5.6>=5.5. Top dim: Value at 9.3; weakest: Technical at 1.9. No conviction either direction.
The strongest dimensions are Value at 9.3, Sentiment at 6.7, and Quality at 6.4; the weakest are Technical at 1.9, Insider at 3.8, and Growth at 4.8. The V9 engine cleared all gates, producing an asymmetric reward-to-risk of 2.41 and an engine sizing output of STARTER.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1At a forward price-to-earnings of 3.8x and a PEG of 0.23, the stock screens at a deep discount relative to earnings power, with price-to-sales at the top of the peer group — implying that the market is pricing in a degree of structural impairment that the current financial results do not support.
Trip ifForward EPS estimates decline more than 25% from current levels over 2 consecutive quarters, indicating earnings deterioration is driving the low multiple rather than mispricing.
- P2Free cash flow represents 146% of net income, meaning the business is generating substantially more cash than reported earnings indicate — a quality signal that underpins the valuation argument and confirms the business is not masking a cash-depleting structure beneath an attractive-looking income statement.
Trip ifFree cash flow falls below 80% of net income for 2 consecutive quarters.
- P3The company delivered beats in the most recent quarter and two quarters prior — surprises of 5.44%, 8.42%, and 18.59% — with one intervening miss of 5.59%, indicating that the earnings trajectory has re-established positive momentum and the single off-quarter was not the start of a deteriorating trend.
Trip ifEPS surprise stays below 0% for 2 consecutive quarters.
- P4Weight management products account for over half of revenue at 54.5%, and the distribution network relies entirely on independent members — a dual concentration that leaves the business highly sensitive to category trends and the health of the direct-sales channel.
Trip ifRevenue grows more than 5% year-over-year for 3 consecutive quarters, indicating the concentrated model is expanding and the vulnerability thesis no longer holds.
- P5A put/call ratio of 2.43 and implied volatility near 87% place the options market in a heavily bearish stance, indicating substantial institutional hedging or directional bets against the stock that can create a persistent drag on price appreciation even as fundamentals improve.
Trip ifPut/call ratio falls below 1.0 for 2 consecutive months, signaling the options-market bearish positioning has fully unwound.